CorMedix Inc. (NASDAQ: CRMD) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CORMEDIX INC.

CorMedix Inc. (NASDAQ: CRMD)
Listen to this Section


$8.47
-0.0750 ( -0.88% ) 473.8K

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.

Clinical Trial Pipeline Stages


Drug Name Stage
DefencathDetailsInfectious disease, Catheter related blood stream infections Approved

Market Data


Open $8.47
Previous Close $8.54
Volume 473.8K
Market Cap $645.66M
Day Range $8.13 - $8.67
52 Week Range $6.13 - $17.43
Shares Outstanding 78.45M
Change % -0.88%
Net Change ▼ -0.0750
Insider Ownership -0.02%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2010
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -501,254.00

Date Type Amount Purchased Purchaser
2025-10-27 Buy 25000.00 Kaplan Myron
2024-12-13 Buy 1500.00 Mistry Erin
2024-05-13 Sale -26982.00 Todisco Joseph
2024-03-20 Sale -30000.00 Stewart Robert A
2024-03-20 Sale -30000.00 Duncan Gregory Scott
2024-03-20 Sale -30000.00 DUNTON ALAN W
2024-03-20 Sale -30000.00 Dillione Janet
2024-03-20 Sale -30000.00 Kaplan Myron
2024-03-20 Sale -30000.00 Lefkowitz Steven W
2024-03-14 Buy 13561.00 Todisco Joseph

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Sep 03, 2025
3 Insider transactions 1 Sep 03, 2025
8-k 8K-related 19 Sep 02, 2025
8-k 8K-related 20 Aug 12, 2025
10-q Quarterly Reports 65 Aug 07, 2025
8-k 8K-related 37 Aug 07, 2025
8-k 8K-related 19 Jun 30, 2025
8-k 8K-related 12 Jun 25, 2025
8-k 8K-related 14 Jun 23, 2025

Latest News


× Before browsing our site, please accept our cookies policy